Skip to main content
. 2005 Feb 1;92(3):547–552. doi: 10.1038/sj.bjc.6602375

Figure 2.

Figure 2

Recurrence-free survival for oestrogen receptor-positive patients with decreased (<0.28) and normal (>0.28) expression of 17β-hydroxysteroid dehydrogenase (HSD) type 2 mRNA (n=133 and n=46, respectively).